Take a sneak peek at the new NIST.gov and let us know what you think!
(Please note: some content may not be complete on the beta site.).
See up to date information and future consortium reports at the new website www.genomeinabottle.org.
Clinical application of ultra high throughput sequencing (UHTS) or “Next Generation Sequencing” for hereditary genetic diseases and oncology is rapidly growing. At present, there are no widely accepted genomic standards or quantitative performance metrics for confidence in variant calling. These are needed to achieve the confidence in measurement results expected for sound, reproducible research and regulated applications in the clinic. On April 13, 2012, NIST convened the workshop “Genome in a Bottle” to initiate a consortium to develop the reference materials, reference methods, and reference data needed to assess confidence in human genome variant calls. A principal motivation for this consortium is to develop widely accepted reference materials and accompanying performance metrics to provide a strong scientific foundation for the development of regulations and professional standards for clinical sequencing.
At present, we expect the consortium to have four working groups with the listed responsibilities:
select appropriate cell lines for whole genome RMs and design synthetic DNA constructs that could be spiked-in to samples
design and carry out experiments to characterize the RMs using multiple sequencing methods, other methods, and validation of selected variants using orthogonal technologies
develop methods to analyze and integrate the data for each RM, as well as select appropriate formats to represent the data.
develop useful performance metrics and figures of merit that can be obtained through measurement of the RMs.
The products of these working groups will be a set of well-characterized whole genome and synthetic DNA RMs along with the methods (documentary standards) and reference data necessary for use of the RMs. These products will be designed to help enable translation of whole genome sequencing to clinical applications by providing widely accepted materials, methods, and data for performance assessment.
An open meeting will be held August 16-17, 2012 at the National Institute of Standards and Technology in Gaithersburg, MD to receive public comment on this proposed work plan for the “Genome in a Bottle” Consortium.
August 16, 2012 - 9:30 AM to 5:30 PM
Visitors will need to go through security at the NIST gate, and must bring their passport (if non-US citizen) or driver's license and vehicle registration (if applicable). The meeting will be held in building 215 on the NIST campus, and we hope to arrange for transport to/from the NIST gate at the beginning and end of the meeting for those who don't have a car. More details about the location within NIST will follow.
John Carpten - Translational Genomics Research Institute (TGen)
George Church - Harvard Medical School
Elliott Margulies - Illumina
Ryan Poplin - Broad Institute
Start Date: Thursday, August 16, 2012
End Date: Friday, August 17, 2012
Location: NIST Gaithersburg, Bldg 101, Green Auditorium
Audience: Industry, Government, Academia, Healthcare Providers
Registration is free for all attendees directly at this link. Please register by Aug. 9 so you can be entered in the NIST visitor system.
Angela Ellis (301) 975-3881
Information about travel to NIST and local hotels with shuttles to NIST is in this document. NIST is accessible from BWI, DCA, and IAD airports. As described in the attached document, the metro goes between DCA and Shady Grove, and a bus travels directly from BWI to the NIST gate. IAD is accessible by car or taxi.